STRATEGIES FOR THE USE OF DISEASE-MODIFYING ANTI-RHEUMATIC DRUGS IN PSORIATIC ARTHRITIS, INCLUDING TREAT TO TARGET

被引：0
|
作者：
Helliwell, Philip [1 ,2 ]
机构：
[1] Univ Leeds, Leeds Inst Rheumat & Musculoskeletal Med, Leeds, W Yorkshire, England
[2] Chapel Allerton Hosp, Leeds, W Yorkshire, England
来源：
RHEUMATOLOGY | 2016年 / 55卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
I111
引用
收藏
页码：22 / 22
页数：1
相关论文
共 50 条
  • [1] Can traditional disease-modifying anti-rheumatic drugs be withdrawn or tapered in psoriatic arthritis?
    Lubrano, E.
    Soriano, E.
    FitzGerald, O.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2013, 31 (04) : S54 - S58
  • [2] RHEUMATOID-ARTHRITIS - DISEASE-MODIFYING ANTI-RHEUMATIC DRUGS
    KIRWAN, JR
    CURREY, HLF
    CLINICS IN RHEUMATIC DISEASES, 1983, 9 (03): : 581 - 599
  • [3] USE OF DISEASE-MODIFYING ANTI-RHEUMATIC DRUGS FOR RHEUMATOID ARTHRITIS IN QUEBEC, CANADA
    Roussy, J. P.
    Bessette, L.
    Bernatsky, S.
    Rahme, E.
    Legare, J.
    Lachaine, J.
    VALUE IN HEALTH, 2011, 14 (07) : A316 - A316
  • [4] Use of Disease-Modifying Anti-Rheumatic Drugs for Rheumatoid Arthritis in Quebec, Canada
    Roussy, Jean-Pascal
    Bessette, Louis
    Bernatsky, Sasha
    Rahme, Elham
    Legare, Jean
    Lachaine, Jean
    ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S855 - S855
  • [5] Effect of disease-modifying anti-rheumatic drugs on bone structure and strength in psoriatic arthritis patients
    Simon, David
    Kleyer, Arnd
    Bayat, Sara
    Tascilar, Koray
    Kampylafka, Eleni
    Meinderink, Timo
    Schuster, Louis
    Petrov, Ramona
    Liphardt, Anna-Maria
    Rech, Juergen
    Schett, Georg
    Hueber, Axel J.
    ARTHRITIS RESEARCH & THERAPY, 2019, 21 (1)
  • [6] IMPACT OF BIOLOGIC DISEASE-MODIFYING ANTI-RHEUMATIC DRUGS IN LIPID PROFILE OF PSORIATIC ARTHRITIS PATIENTS
    Guajardo-Aldaco, Andrea L.
    Galarza-Delgado, Dionicio A.
    Azpiri-Lopez, Jose R.
    Colunga-Pedraza, Iris J.
    Cardenas-de la Garza, Jesus A.
    Arvizu-Rivera, Rosa I.
    Elizondo-Benitez, Maria F.
    Gonzalez-Gonzalez, Valeria
    ACTA DERMATO-VENEREOLOGICA, 2024, 104
  • [7] Effect of disease-modifying anti-rheumatic drugs on bone structure and strength in psoriatic arthritis patients
    David Simon
    Arnd Kleyer
    Sara Bayat
    Koray Tascilar
    Eleni Kampylafka
    Timo Meinderink
    Louis Schuster
    Ramona Petrov
    Anna-Maria Liphardt
    Juergen Rech
    Georg Schett
    Axel J. Hueber
    Arthritis Research & Therapy, 21
  • [8] EFFECT OF DISEASE-MODIFYING ANTI-RHEUMATIC DRUGS ON BONE STRUCTURE AND STRENGTH IN PSORIATIC ARTHRITIS PATIENTS
    Simon, David
    Bayat, Sara
    Tascilar, Koray
    Kampylafka, Eleni
    Meinderink, Timo
    Schuster, Louis
    Liphardt, Anna-Maria
    Rech, Juergen
    Hueber, Axel
    Schett, Georg
    Kleyer, Arnd
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 1287 - 1287
  • [9] Pharmacogenetics of disease-modifying anti-rheumatic drugs
    Tanaka, E
    Taniguchi, A
    Urano, W
    Yamanaka, H
    Kamatani, N
    BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY, 2004, 18 (02): : 233 - 247
  • [10] Disease-modifying anti-rheumatic drugs - Cyclosporin
    Chaudhuri, K
    Torley, H
    Madhok, R
    BRITISH JOURNAL OF RHEUMATOLOGY, 1997, 36 (09): : 1016 - 1021
12345